Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND: ctDNA-Guided Treatment Adaptation in Metastatic Colorectal Cancer
NCT06446557Phase 3Not yet recruiting
- Sponsor
- Rouen University Hospital
- Start
- Jun 2026
- Primary completion
- Jun 2032
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Quality-adjusted Overall Survival at 7 years. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06446557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446557.